These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28493121)

  • 1. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
    Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoengineering Chinese hamster ovary cells: a short history.
    Donini R; Haslam SM; Kontoravdi C
    Biochem Soc Trans; 2021 Apr; 49(2):915-931. PubMed ID: 33704400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody glycoengineering strategies in mammalian cells.
    Wang Q; Chung CY; Chough S; Betenbaugh MJ
    Biotechnol Bioeng; 2018 Jun; 115(6):1378-1393. PubMed ID: 29457629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
    Thi Sam N; Misaki R; Ohashi T; Fujiyama K
    J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOGlycoNET: Comprehensive glycosylation reaction network for CHO cells.
    Kotidis P; Donini R; Arnsdorf J; Hansen AH; Voldborg BGR; Chiang AWT; Haslam SM; Betenbaugh M; Jimenez Del Val I; Lewis NE; Krambeck F; Kontoravdi C
    Metab Eng; 2023 Mar; 76():87-96. PubMed ID: 36610518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation control technologies for recombinant therapeutic proteins.
    Gupta SK; Shukla P
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins.
    Weikert S; Papac D; Briggs J; Cowfer D; Tom S; Gawlitzek M; Lofgren J; Mehta S; Chisholm V; Modi N; Eppler S; Carroll K; Chamow S; Peers D; Berman P; Krummen L
    Nat Biotechnol; 1999 Nov; 17(11):1116-21. PubMed ID: 10545921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoengineering in CHO Cells: Advances in Systems Biology.
    Tejwani V; Andersen MR; Nam JH; Sharfstein ST
    Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.
    Spahn PN; Hansen AH; Hansen HG; Arnsdorf J; Kildegaard HF; Lewis NE
    Metab Eng; 2016 Jan; 33():52-66. PubMed ID: 26537759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.
    Sha S; Agarabi C; Brorson K; Lee DY; Yoon S
    Trends Biotechnol; 2016 Oct; 34(10):835-846. PubMed ID: 27016033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.
    Baker KN; Rendall MH; Hills AE; Hoare M; Freedman RB; James DC
    Biotechnol Bioeng; 2001 May; 73(3):188-202. PubMed ID: 11257601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic engineering challenges of extending N-glycan pathways in Chinese hamster ovary cells.
    Wang Q; Wang T; Yang S; Sha S; Wu WW; Chen Y; Paul JT; Shen RF; Cipollo JF; Betenbaugh MJ
    Metab Eng; 2020 Sep; 61():301-314. PubMed ID: 32663509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered CHO cells for production of diverse, homogeneous glycoproteins.
    Yang Z; Wang S; Halim A; Schulz MA; Frodin M; Rahman SH; Vester-Christensen MB; Behrens C; Kristensen C; Vakhrushev SY; Bennett EP; Wandall HH; Clausen H
    Nat Biotechnol; 2015 Aug; 33(8):842-4. PubMed ID: 26192319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Producing Biologics with Defined N-Glycosylation in Plants.
    Esqueda A; Chen Q
    Methods Mol Biol; 2023; 2597():235-250. PubMed ID: 36374425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoproteins from insect cells: sialylated or not?
    Marchal I; Jarvis DL; Cacan R; Verbert A
    Biol Chem; 2001 Feb; 382(2):151-9. PubMed ID: 11308014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells.
    Lee CG; Oh MJ; Park SY; An HJ; Kim JH
    Sci Rep; 2018 May; 8(1):7273. PubMed ID: 29740059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.